U.S. Senator Rob Portman's (R-Ohio) measure to strengthen states' ability to monitor and track prescription drug dispersion was included in the final version of the FDA bill that passed the Senate yesterday. The legislation now goes to the President's desk for his signature.
"Creating a national standard for states to exchange information from prescription drug monitoring programs (PDMPs) will give states a new tool in the fight against prescription drug abuse that is plaguing Ohio communities," Senator Portman said.
Portman's measure creates an efficient, cost-effective system for states to share information from prescription drug monitoring programs (PDMPs) across state lines, making it easier to track prescription drug abuse. Forty-eight states have authorized PDMPs to facilitate the exchange of information among doctors, pharmacists and in some instances, authorized law enforcement, but currently there is no national standard for the exchange of such information across state lines. The amendment is based on S.2254, the Interstate Drug Monitoring Efficiency and Data Sharing Act of 2012 (ID MEDS), which was introduced by Sens. Portman, Whitehouse (D-RI) and U.S. Representative Hal Rogers (R-KY) earlier this year.
Following a roundtable in Scioto County with Office of National Drug Control Policy (ONDCP) Director Gil Kerlikowske last July, Portman introduced the legislation because of concerns expressed by southern Ohio local law enforcement regarding their inability to access databases in neighboring states.